A groundbreaking clinical trial investigates the integration of wearable devices and intelligent platforms to improve perioperative management for non-small cell lung cancer (NSCLC). Sponsored by West China Hospital, the system combines digital rehabilitation tools with traditional perioperative strategies. Clinical, quality, and regulatory professionals should take note of this innovation in lung cancer care.
- What is the study?
- How does it work?
- Who is affected?
- Key takeaways
- FAQ
- Conclusion
- Disclaimer
- Source and link
What is the study?
The West China Hospital has initiated a trial exploring a wearable-based digital perioperative rehabilitation system. This initiative targets patients with non-small cell lung cancer undergoing thoracic surgery. The trial incorporates standard perioperative rehabilitation guidance, supported by advanced wearable technologies. As of January 2026, recruitment for this trial has not yet begun.
How does it work?
The system under investigation integrates wearable devices with a digital platform to assist patients during their perioperative journey. This dual approach aims to enhance patient outcomes by continuously monitoring vital parameters, rehabilitation exercise adherence, and recovery metrics. The wearable system delivers actionable insights to clinicians, allowing more personalized care, while standard behavioral rehabilitation guidance complements the technology-based solution.
Key interventions in focus
The major components of the trial include:
- Wearable-Based Digital Perioperative Rehabilitation System: An intelligent device designed to provide comprehensive monitoring and digital support during the perioperative period.
- Standard Perioperative Rehabilitation Guidance: Evidence-based behavioral recommendations to facilitate recovery and reduce surgical risks.
Who is affected?
The target population includes individuals diagnosed with non-small cell lung cancer, particularly those scheduled for thoracic surgical procedures. This demographic represents a high-risk group due to both the complexity of lung surgery and associated rehabilitation challenges. Physicians, surgical teams, and regulatory oversight organizations may also be impacted by the systemic adoption of such digital health innovations.
Key takeaways
Once recruiting begins and clinical data is captured, this study could set a precedent for integrating wearable devices into broader perioperative care standards. Valuable implications include improved patient outcomes, better adherence to rehabilitation protocols, and enhanced clinician-patient interactions driven by intelligent health monitoring. If successful, such a model could extend to other surgical and rehabilitative applications, prompting regulatory interest in device validation and effectiveness studies.
FAQ
- 1. What is the purpose of this study?
- The trial seeks to assess the effectiveness of a wearable-based rehabilitation system designed to improve lung cancer perioperative management.
- 2. Who is conducting this research?
- The study is sponsored by West China Hospital.
- 3. What conditions does this study address?
- This research focuses on non-small cell lung cancer (NSCLC) patients undergoing thoracic surgery.
- 4. When does recruitment start?
- Recruitment has not yet started as of January 12, 2026.
- 5. How can I access more details?
- Visit the official ClinicalTrials.gov record provided below.
Conclusion
This trial represents a significant step forward in digital and wearable health technology, specifically tailored for perioperative care in oncology. By integrating advanced devices with traditional guidance, the system offers potential for greater recovery success and patient satisfaction. Interested professionals should monitor updates as the trial progresses.
Disclaimer
This article is intended for informational purposes only. It does not constitute legal, medical, or regulatory advice. Readers should consult appropriate professionals for specific guidance.
Source and link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07310056?term=medical+device